• 13F History

Faithward Advisors, LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 13, 2025
Value $
$587M
Signature - Title
Adrian Evan Young - Managing Member/Chief Compliance Officer
Location
Lancaster, PA
Summary
This page shows a list of all the recent 13F filings made by Faithward Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Faithward Advisors, LLC reported 253 stock holdings with total value $587M as of Q4 2024. Top holdings included IBD, GLRY, ELCV, AGZ, and WWJD.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 253 $587M +$71.8M -$70.3M +$1.52M IBD, GLRY, ELCV, AGZ, WWJD 13F-HR 2/13/2025, 10:37 AM
Q3 2024 280 $575M +$48M -$38.2M +$9.85M IBD, GLRY, WWJD, AGZ, BITO 13F-HR 11/14/2024, 04:51 PM
Q2 2024 252 $553M +$73.2M -$57.3M +$15.9M IBD, GLRY, WWJD, AGZ, BITO 13F-HR 8/14/2024, 02:59 PM
Q1 2024 251 $551M +$82M -$21M +$61M IBD, IBTE, GLRY, BITO, WWJD 13F-HR 5/15/2024, 02:40 PM
Q4 2023 248 $439M +$41.7M -$45.7M -$4.03M IBD, IBTE, GLRY, WWJD, BITO 13F-HR 2/14/2024, 05:31 PM
Q3 2023 272 $378M +$30.7M -$44M -$13.4M IBD, GLRY, WWJD, IBTE, SCHQ 13F-HR 11/14/2023, 07:58 PM
Q2 2023 319 $423M +$25.6M -$49.5M -$23.9M SCHQ, GLRY, IBD, WWJD, BITO 13F-HR 8/14/2023, 07:36 PM
Q1 2023 301 $425M +$77M -$104M -$27.5M IBD, GLRY, SCHQ, WWJD, IVOL 13F-HR 5/15/2023, 05:08 PM
Q4 2022 266 $460M +$134M -$91.8M +$41.8M GLRY, IBD, SCHQ, WWJD, TPLC 13F-HR 2/14/2023, 01:26 PM
Q3 2022 234 $420M +$121M -$109M +$12M IBD, TPLC, WWJD, VGSH, IVOL Restatement 11/18/2022, 08:25 AM
Q2 2022 252 $445M +$42.4M -$24.9M +$17.5M IBD, FEVR, BIBL, GLRY, IEF 13F-HR 8/12/2022, 01:13 PM
Q1 2022 264 $514M +$33.8M -$10.1M +$23.7M IBD, FEVR, IVOL, BIBL, GLRY 13F-HR 5/16/2022, 12:30 PM
Q4 2021 261 $472M +$58M -$81.8M -$23.8M IBD, FEVR, IVOL, GLRY, IEF 13F-HR 2/14/2022, 04:21 PM
Q3 2021 277 $514M +$37.7M -$22.4M +$15.4M IBD, FEVR, IVOL, GLRY, PDBC 13F-HR 11/15/2021, 05:44 PM
Q2 2021 264 $505M +$145M -$121M +$23.8M IBD, FEVR, IVOL, GLRY, PDBC 13F-HR 8/13/2021, 05:37 PM
Q1 2021 238 $447M +$254M -$39.5M +$214M IBD, IEI, GLRY, IEF, FEVR 13F-HR 5/13/2021, 04:17 PM
Q4 2020 118 $229M +$56.2M -$29.9M +$26.3M IBD, GLRY, FEVR, WWJD, VMBS 13F-HR 2/16/2021, 05:04 PM
Q3 2020 209 $413M +$113M -$81.6M +$31.7M IEI, IBD, IEF, WWJD, TPLC 13F-HR 11/13/2020, 08:37 AM
Q2 2020 206 $385M +$113M -$61.6M +$51.8M IEF, TPLC, WWJD, VMBS, SHY 13F-HR 8/13/2020, 10:49 AM
Q1 2020 236 $355M +$100M -$98.4M +$1.83M IEF, TPLC, ISMD, VMBS, JPMF 13F-HR 5/11/2020, 09:20 PM
Q4 2019 239 $421M +$199M -$221M -$21.4M TPLC, ISMD, IEF, TIP, RINF 13F-HR 1/22/2020, 03:40 PM
Q3 2019 101 $452M RINF, ISMD, BLES, IBD, LEMB 13F-HR 11/14/2019, 06:02 PM